Reuters logo
BRIEF-Intersect ENT announces positive clinical results of pivotal study of RESOLVE In-Office steroid releasing implant
October 17, 2016 / 12:26 PM / in a year

BRIEF-Intersect ENT announces positive clinical results of pivotal study of RESOLVE In-Office steroid releasing implant

Oct 17 (Reuters) - Intersect Ent Inc

* Intersect ENT announces positive clinical results of pivotal study of resolve in-office steroid releasing implant

* RESOLVE II clinical study met both primary efficacy endpoints: reduction in nasal congestion and polyp burden

* Intersect plans to submit a new drug application (NDA) in Q1 of 2017 for regulatory approval from FDA to market resolve product Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below